Deliverable: PowerPoint Presentation

Primary Objective: Evaluate the competitive landscape of the dermal fillers market

Objectives:

• Understand current perceptions and usage patterns of dermal fillers
• Determine the market potential of Juvederm within the dermal fillers market
• Assess current use of laser treatment procedures
• Gauge perceptions and market potential of novel dermal fillers

Products Highlighted:

• Botox^® Cosmetic (botulinum toxin type A), Allergan
• Collagen
• Juvederm™, Allergan
• Puretox^® (botulinum toxin type A), Mentor
• Reloxin^® / Dysport^® (botulinum toxin type A), Medicis
• Restylane^®, Medicis

Topics:

• Current use of dermal fillers
• Project use of dermal fillers over the course of 2007
• Frequency and rationale for switching patients from Restylane to Juvederm
• Use of and satisfaction with laser therapy treatments from 2005 through 2007
• Anticipated use of Botox in 2007 compared with use in 2006
• Overall impression of botulinum toxin type A products

Sample:

• 51 respondents in total (26 dermatologists, 25 plastic surgeons)

Screening Criteria:

• Have been in practice between 2 and 30 years
• Spend at least 75% of their professional time in clinical practice
• Treat at least 15 patients per month using collagen/hyaluronic acid dermal fillers
• Treat at least 15 patients per month using BOTOX cosmetic treatment